Braune S, Grimm S, van Hövell P, et al. Delayed-release dimethyl fumarate demonstrated no evidence of difference in clinical outcomes vs fingolimod in patients with RRMS: a propensity-matched comparative effectiveness analysis of the German NeuroTransData registry. ECTRIMS 2017, #P651.
Cognitieve problemen bij MS: balans tussen hersenstructuur en -functie
okt 2018 | Multipele Sclerose